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and mortality. However, reperfusion presents also deleterious effects such
as ischemia-reperfusion (IR) injury due to irreversible apoptotic death of
cardiomyocytes. Heart rate (HR) is also a determinant of cardiac
pathology. Most ischemic episodes are triggered by an increase in HR that
induces an imbalance between myocardial oxygen delivery and consump-
tion. The BEAUTIFUL clinical trial (Fox et al. the Lancet, 2008) has dem-
onstrated that moderate HR reduction diminishes the frequency of
episodes MI in patients with stable coronary artery disease and increased
HR at rest. The HCN-mediated If current and the Cav1.3-mediated L-type
Ca2+ currents play important roles in the generation of automaticity and
HR, therefore they are interesting targets for selective control of HR and
cardioprotection (reduced IS) during acute MI. The aim of our study was
to investigate if targeting Cav1.3 channels could be an efficient strategy to
reduce IS. Cav1.3 –/– mice was used as a genetic model of Cav1.3 inhibi-
tion because of the lack of selective blocker. Ivabradine (Iva), the selective
f-channel blocker, was used for pure HR reduction as a positive control.
Results show that selective HR decrease (40%) in an in vivo mouse model
of acute MI is associated with reduced IR injury. Ivabradine administration
30 minutes before ischemia significantly reduced IS (35%). Cav1.3 –/– mice
presented reduced IS compared to WT mice (30%). In addition, prelimi-
nary results show that Girk4 –/– mice, a genetic model of moderate sinus
node tachycardia (10%) displayed increased IS compared to control mice
(45%). Taken together these results suggest a direct relationship between
HR and IR injury and that inhibition of Cav1.3 channels constitutes a
promising strategy to reduce both HR and IS.
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Background: Rescue percutaneous coronary intervention (PCI) is associ-
ated with improved clinical outcomes for ST-segment myocardial infarction
(STEMI) patients after failed fibrinolysis therapy. Hyperglycemia on admis-
sion has been shown to be a powerful predictor of mortality after acute myo-
cardial infarction, particularly in non-diabetic patients. The aim of our study
was to assess the predictive value of admission glucose levels on long-term
mortality in patients with rescue PCI.
Patients and Methods: From the "Observatoire des infarctus de Côte
d’Or" (RICO) survey, 510 consecutive non-diabetic STEMI patients admitted
to the intensive care unit for rescue PCI after failed fibrinolysis therapy were
included in the study. We analyzed one-year cardiovascular mortality in these
patients. Rescue PCI was deemed necessary in patients with ST-segment res-
olution <50% 90 minutes after lysis, or a thrombolysis in myocardial infarc-
tion (TIMI) perfusion grade in the infarct-related artery <3 at the time of
angiography in patients with persisting equivocal symptoms. Patients were
classified according to admission glycemia: <11 mmol/L (group I, n=452) and
≥11 mmol/L (group II, n=58).
Results: One-year cardiovascular (CV) mortality was 6% in group I
and 29% in group II (p<0.001). Patients with hyperglycemia on admission
were more likely to develop cardiogenic shock (43% vs. 10%, p<0.001)
and to have higher peak CPK (4052(2465-6283) vs. 2667 (1303-4865),
p=0.007), reflecting a bigger infarct size than the others, although the
revascularization results were similar. By multivariate analysis, glycemia
on admission ≥11 mmol/L (odds ratio 6.380, 95% confidence interval
2.075 to 19.617, p=0.001) and GRACE risk score (OR: 1.027, 95% CI
1.012-1.042, p<0,001) were independently associated with 1-year CV mor-
tality.
Conclusion: In non-diabetic patients undergoing rescue PCI after failed
fibrinolysis, glycemia on admission is a predictive factor for long-term CV
survival. This study suggests that evaluating early glycemic control may be
useful in the setting of rescue PCI.
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Background: Myocardial infarction (MI)-related cardiogenic shock (CS)
remains associated with major mortality rates. Trans-radial approach for per-
cutaneous coronary intervention (PCI) has been associated with better out-
come in the setting of MI but patients with CS were excluded.
Objectives: To assess the outcome of MI-related CS in patients treated by
trans-radial versus trans-femoral approach.
Methods: A prospective cohort of 101 consecutive patients admitted for
PCI for MI-related CS were treated by trans-radial (n=74) or trans-femoral
(n=27) approach. Cox proportional hazards models adjusted on age, gender,
GRACE score -CRUSADE score for bleeding-, and need for intra-aortic bal-
loon pump were used to assess mortality, death/MI/Stroke and bleeding
between the two groups.
